AbbVie awards 2 biopharmaceutical companies 'golden tickets'

AbbVie and MBC BioLabs named Bacchus Therapeutics and PTM Therapeutics recipients of the 2020 AbbVie Golden Ticket.

What you should know:

1. Each company will receive one year of laboratory bench space and access to core facilities at MBC BioLabs.

2. The companies will also have opportunities to interact with AbbVie's scientific and business leaders.

3. AbbVie began sponsoring the Golden Ticket program in 2018 to support the therapy development efforts of early-stage biotech companies

4. A team of scientific and business leaders selected Bacchus and PTM from a pool of applicants.

More articles on surgery centers:
The 'new normal' for ASCs: 16 admins on how the pandemic will change the field forever
Dr. Thomas Vikoren: Same-day TJR 'made all the more important' by COVID-19
Indiana orthopedic practice with surgery center to open 

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

ASC_GI_300x250

Featured Webinars

Featured Whitepapers

Featured Podcast